glutathione thomas wward Ward Frontiers | Preclinical investigations of
Frontiers Preclinical investigations of the efficacy of the glutaminase inhibitor CB 839 alone and in combinations in chronic lymphocytic leukemia Thomas Ward Lead ISO Consultant Turning Compliance into Business Advantage 9001 13485 14001 IATF 16949); Proud Member of the 5am Club LinkedIn Frontiers Metabolism of Amino Acids in Cancer Metabolically reprogrammed eosinophils impair T cell immunity and cause chronic skin infection EMBO Molecular Medicine Springer Nature Link
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


